Bausch Health Companies (BHC) Stock Highlights

8.02 | +11.7%

2024-09-19 02:14:03

Formerly known as Valeant Pharmaceuticals, Bausch Health is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Bausch+Lomb (45% of revenue), Salix Pharmaceuticals (24%), international pharma (14%), ortho dermatology (7%), and diversified products (10%). Bausch is the market leader in consumer visioncare in India and China and the fourth-largest visioncare company by sales in the United States.

Statistics

Range Today

7.39 8.11

Volume Today 8.16M

Range 1 Year

3.96 11.46

Volume 1 Year 742.55M

Range 3 Year

3.96 29.58

Volume 3 Year 3.19B

Range 10 Year

3.96 263.81

Volume 10 Year 19.97B

Highlights

Market Capitalization 2.32B (mid)

Floating Shares 275.87M

Current Price 8.02

Price To Earnings -4.91

Price To Revenue 2.65

Earnings Per Share -1.29

Payout Ratio 0%

Performance

Latest +11.7%

1 Month +39.48%

3 Months +24.53%

6 Months -13.67%

1 Year -4.86%

3 Years -69.89%

5 Years -65.13%

10 Years -93.42%

Benchmarks

Market Capitalization

10 / 54

Gross Profits

2 / 39

Total Revenue

3 / 50

Total Rank

30 / 54

Free Cashflow

3 / 54

Performance 5 years

34 / 54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.